Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

AbCellera Biologics Inc. Common Shares (ABCL)

Pharmaceutical Preparations

https://www.abcellera.com

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the most effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and leading pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

2215 YUKON STREET
VANCOUVER, A1

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/11/2020

Market Cap

780,864,900

Shares Outstanding

290,170,000

Weighted SO

290,170,241

Total Employees

N/A

Upcoming Earnings

08/06/2024

Beta

0.3890

Last Div

0.0000

Range

2.4-6.055

Chg

0.0300

Avg Vol

1648475

Mkt Cap

780864900

Exch

NASDAQ

Country

CA

Phone

604 559 9005

DCF Diff

6.6170

DCF

-3.2820

Div Yield

0.0000

P/S

23.6232

EV Multiple

-3.3683

P/FV

0.7018

Div Yield %

0.0000

P/E

-5.0859

PEG

-0.2073

Payout

0.0000

Current Ratio

10.9627

Quick Ratio

10.9627

Cash Ratio

2.4625

DSO

747.5902

DIO

0.0000

Op Cycle

747.5902

DPO

158.2415

CCC

589.3488

Gross Margin

-0.8551

Op Margin

-8.1468

Pretax Margin

-5.4095

Net Margin

-4.6377

Eff Tax Rate

0.1427

ROA

-0.1085

ROE

-0.1340

ROCE

-0.2006

NI/EBT

0.8573

EBT/EBIT

0.6640

EBIT/Rev

-8.1468

Debt Ratio

0.0510

D/E

0.0649

LT Debt/Cap

0.0564

Total Debt/Cap

0.0609

Int Coverage

-16.1001

CF/Debt

-1.2613

Equity Multi

1.2714

Rec Turnover

0.4882

Pay Turnover

2.3066

Inv Turnover

999999.9999

FA Turnover

0.1037

Asset Turnover

0.0234

OCF/Share

-0.3089

FCF/Share

-0.5783

Cash/Share

2.3634

OCF/Sales

-2.7495

FCF/OCF

1.8721

CF Coverage

-1.2613

ST Coverage

-16.2206

CapEx Coverage

-1.1467

Div&CapEx Cov

-1.1467

P/BV

0.7018

P/B

0.7018

P/S

23.6232

P/E

-5.0859

P/FCF

-4.5895

P/OCF

-8.5788

P/CF

-8.5788

PEG

-0.2073

P/S

23.6232

EV Multiple

-3.3683

P/FV

0.7018

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation